Oncolytics Biotech (oncy) Misses Q3 EPS by 25c

Oncolytics Biotech (NASDAQ: oncy) reported Q3 EPS of ($0.02), $0.25 worse than the analyst estimate of $0.23.

For earnings history and earnings-related data on Oncolytics Biotech (oncy) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Waste stocks ride AI and healthcare boom as CLH surges 27%
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg